Alternatively, constitutive JAK/STAT signaling can be induced by the acquisition of gain-of-function mutations (e.g., JAK2 V617F) in hematopoietic stem cells leading to myeloproliferative neoplasm (MPN). Here, JAK2 is linked to myeloproliferative neoplasm.